A Potential Alternative Orodispersible Formulation to Prednisolone Sodium Phosphate Orally Disintegrating Tablets. (2021)

First Author: Tawfik EA

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3390/pharmaceutics13010120

PubMed Identifier: 33477855

Publication URI: http://europepmc.org/abstract/MED/33477855

Type: Journal Article/Review

Volume: 13

Parent Publication: Pharmaceutics

Issue: 1

ISSN: 1999-4923